Status:
COMPLETED
Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization
Lead Sponsor:
Asan Medical Center
Conditions:
Procedure-Related Complication
Degree of Liver Regeneration
Eligibility:
All Genders
20-75 years
Phase:
PHASE2
PHASE3
Brief Summary
Portal vein embolization (PVE) induces shrinkage of the embolized lobe and compensatory enlargement of the non-embolized lobe, but it does not always induce sufficient liver regeneration. There was no...
Detailed Description
To prospectively assess the effect of ipsilateral HVE after PVE on liver volume change, this study was designed to continue for 12 months, from March 2007 to February 2008. This study protocol was ap...
Eligibility Criteria
Inclusion
- Patients showing small future remnant liver \< 40% of whole liver volume
Exclusion
- Patients showing small future remnant liver \> 40% of whole liver volume
- Inoperable tumor extent
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00698880
Start Date
March 1 2007
End Date
April 1 2008
Last Update
June 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, Seoul, South Korea, 138-736